BRICA in Global Pharmaceutical Provision

Mei-Ling Wang
Additional contact information
Mei-Ling Wang: University of the Sciences

Chapter 3 in Global Health Partnerships, 2009, pp 81-132 from Palgrave Macmillan

Abstract: Abstract The future of the global pharmaceutical supply and demand chain lies in the development potential of the BRICA countries. BRICA is the abbreviation of Brazil, Russia, India, China and Africa. To begin with, most discussions about the future of the pharmaceutical industry surround the BRIC countries, that is, Brazil, Russia, India and China. The pharmaceutical potential of BRIC lies in its market size, population informatics for prevalent diseases, especially neglected diseases, as well as traditional and plant medicine. However, as the outside world has gained more understanding of the health issues facing Africa, the African continent also constitutes immense potential to be part of the solution of global pharmaceutical supply and demand.

Keywords: Foreign Direct Investment; Pharmaceutical Market; Chinese Market; Compulsory License; Pharmaceutical Sector (search for similar items in EconPapers)
Date: 2009
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:pal:palchp:978-0-230-58287-3_3

Ordering information: This item can be ordered from
http://www.palgrave.com/9780230582873

DOI: 10.1057/9780230582873_3

Access Statistics for this chapter

More chapters in Palgrave Macmillan Books from Palgrave Macmillan
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().